Docetaxel, Pertuzumab, and Trastuzumab

About

Membership operator: AND

Therapies: 3

Therapies

Docetaxel (tx:ncit:C1526)

Pertuzumab (tx:ncit:C38692)

Trastuzumab (tx:ncit:C1647)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy group.

Organizations
Biomarkers
Cancer types
Therapies
Organizations Biomarkers Cancer types Therapies
EMA (4) FDA (4) HER2-positive Invasive Breast Carcinoma Docetaxel, Pertuzumab, Trastuzumab